Cerenome vs Intelligent BIO Solutions
Cerenome is the larger business, with $5.2m of revenue in fiscal 2025 against $4.2m for Intelligent BIO Solutions (1.2 times as much). Intelligent BIO Solutions grew faster (38.1% against -10.5%). Intelligent BIO Solutions kept more of each dollar of sales as profit: a net margin of -294.9% against -429.4%. Intelligent BIO Solutions carries less debt relative to equity (0.0% against 18.8%).
| Latest fiscal year | CerenomeCNSY, 2025 | Intelligent BIO SolutionsINBS, 2026 |
|---|---|---|
| Revenue | $5.2m | $4.2m |
| Revenue growth | -10.5% | 38.1% |
| Net income | −$22.4m | −$12.4m |
| Operating margin | -293.5% | -299.1% |
| Net margin | -429.4% | -294.9% |
| Return on equity | — | — |
| Free cash flow | −$20.8m | −$12.1m |
| Cash | $4.3m | $4.0m |
| Total debt | $750,000 | $0 |
| Debt to equity | 18.8% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 28 | — |
| Market value | $9.6m | $5.1m |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 1 buys, 0 sales | 0 buys, 0 sales |